The American Journal of Surgery
Volume 186, Issue 4 , Pages 368-370 , October 2003

Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ

Presented at the Fourth Annual Meeting of the American Society of Breast Surgeons, Atlanta, Georgia, April 30–May 4, 2003

  • Tricia A Kelly, M.D.

      Affiliations

    • Cleveland Clinic Breast Center, Cleveland Clinic Foundation, Department of General Surgery, A-80, 9500 Euclid Ave., Cleveland, OH 44195, USA
  • ,
  • Julian A Kim, M.D.

      Affiliations

    • Cleveland Clinic Breast Center, Cleveland Clinic Foundation, Department of General Surgery, A-80, 9500 Euclid Ave., Cleveland, OH 44195, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-216-445-3612; fax: +1-216-445-7653.
  • ,
  • Rebecca Patrick, M.A.

      Affiliations

    • Cleveland Clinic Breast Center, Cleveland Clinic Foundation, Department of General Surgery, A-80, 9500 Euclid Ave., Cleveland, OH 44195, USA
  • ,
  • Sharon Grundfest, M.D.

      Affiliations

    • Cleveland Clinic Breast Center, Cleveland Clinic Foundation, Department of General Surgery, A-80, 9500 Euclid Ave., Cleveland, OH 44195, USA
  • ,
  • Joseph P Crowe, M.D.

      Affiliations

    • Cleveland Clinic Breast Center, Cleveland Clinic Foundation, Department of General Surgery, A-80, 9500 Euclid Ave., Cleveland, OH 44195, USA

Received 3 June 2003 ,Revised 21 June 2003

References 

  1. Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg. 2001;25:767–772
  2. Schwartz GF, et al. Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999. Cancer 2000;88:946–54
  3. Pendas S, et al. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000;7:15–20
  4. Klauber-DeMore N, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-Situ with microinvasion? Ann Surg Oncol 2000;7:636–42
  5. Cox CE, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 2001;67:513–21
  6. McMasters KM, et al. Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal. Cancer 2002;95:15–20
  7. Intra M, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 2003;138:309–13

PII: S0002-9610(03)00276-9

doi: 10.1016/S0002-9610(03)00276-9

The American Journal of Surgery
Volume 186, Issue 4 , Pages 368-370 , October 2003